
Catalyst Biosciences CBIO
€ 10.25
-5.08%
Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025
Catalyst Biosciences P/S 2011-2026 | CBIO
P/S Jährlich Catalyst Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.296 | 0.124 | - | 5.95 | - | 16 K | 71.5 | 16.7 | 5.59 | 229 | 31.1 | 1.91 | 1.45 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16 K | 0.124 | 1.49 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Adagene
ADAG
|
35.6 | $ 2.34 | -6.02 % | $ 132 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.97 | 1.34 % | $ 5.29 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.67 | 3.38 % | $ 8.83 B | ||
|
Biogen
BIIB
|
2 | $ 173.65 | 1.2 % | $ 25.3 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 117.58 | 1.38 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.16 | -6.0 % | $ 116 M | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.79 | -1.64 % | $ 4.54 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 233.81 | -0.67 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.74 | -0.05 % | $ 1.57 B | ||
|
Cytokinetics, Incorporated
CYTK
|
0.286 | $ 64.11 | 1.11 % | $ 7.18 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 67.54 | 0.74 % | $ 9.03 B | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.06 | -1.67 % | $ 184 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.43 | -0.78 % | $ 9.64 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.33 | 1.58 % | $ 1.28 B | ||
|
Coherus BioSciences
CHRS
|
0.813 | $ 2.23 | 8.01 % | $ 210 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 13.56 | 1.27 % | $ 4.19 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 26.55 | 2.43 % | $ 1.71 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.75 | 1.85 % | $ 17.3 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 94.47 | 1.64 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B |